Clinical Trial Update: Dapagliflozin Therapy In Cardiac Surgery [Phase 4]

View source ↗

Summary

This update reports completion of a Phase 4 trial evaluating dapagliflozin therapy in adults with type 2 diabetes undergoing cardiac surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Diabetes Mellitus, Type 2, Cardiac Surgery | Phase 4 | Status: COMPLETED